October 26, 2015 Lifestyle changes can help manage Crohn’s disease Crohn’s disease affects over half a million Americans of all ages, according to the Crohn’s & Colitis Foundation of America (CCFA). Classified as an inflammatory bowel disease (IBD), Crohn’s causes swelling and inflammation in the lining of your digestive tract, typically resulting in abdominal pain and diarrhea. While the cause is unknown and no cure is available, ongoing treatment can help alleviate the symptoms of Crohn’s disease and prevent life-threatening complications, such as severe malnutrition.
October 26, 2015 Kitchen cures for autoimmune disease For 23 million Americans who suffer from chronic autoimmune disease, finding foods that don’t irritate the body can be a daily struggle. Dr. Manny talks with author Mee Tracy McCormick, who after a nearly fatal fight with Crohn’s disease, found the cure right in her own kitchen
October 24, 2015 Boy's ear problems had rare cause: gut disease A 10-year-old boy in North Carolina suffered from ear pain and hearing problems for years before doctors were finally able to crack the case: He did not have an ear condition after all, but an underlying disease in the gut
October 24, 2015 Atlanta family raising awareness for Crohn’s after children receive diagnosis An Atlanta family whose two children were diagnosed with Crohn’s disease is working to raise awareness and help others cope with the incurable, painful digestive disorder.
October 23, 2015 Biomarkers in urine may help detect kidney cancer early, study finds More than 80 percent of patients whose kidney cancer isn’t discovered until after it has spread will die within five years, and current tests for the disease are dependent on whether a patient has started showing symptoms.
October 23, 2015 Celebrity chef Sunny Anderson on living with inflammatory bowel disease I may be best known for my Food Network shows, where I whip up my favorite meals and share recipes I love on “The Kitchen” and “Cooking for Real,” but many fans may not know that I’ve been living with inflammatory bowel disease (IBD) for about 20 years, specifically, ulcerative colitis (UC).
October 20, 2015 Johnson & Johnson's Stelara succeeds in Phase III Crohn's disease trial Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine.
